Faecal Extraction System Market Analysis

  • Report ID: 4061
  • Published Date: Sep 30, 2025
  • Report Format: PDF, PPT

Faecal Extraction System Market Segmentation:

Technology Segment Analysis

Based on the technology, the automated/suction-based systems segment in the faecal extraction system market is anticipated to account for the largest share of 83.5% by the end of 2035. The segment’s growth is highly attributed to its capability to effectively enhance the efficacy and precision in tasks, such as healthcare and manufacturing, while boosting safety and diminishing expenses. In this regard, the March 2022 NLM article stated that a real-time cognitive workload assessment system can be utilized to successfully detect 80% of accuracy. Therefore, with the existence of a standard system, there is a huge growth opportunity for the segment.

Indication Segment Analysis

Based on the indication, the chronic faecal incontinence segment in the faecal extraction system market is projected to cater the second-largest share during the predicted timeline. The segment’s growth is highly fueled by the aspect of addressing economic, health, and social burden, and impacting the quality of life. According to an article published by NLM in September 2022, fecal incontinence incidence ranges from 2% to 21%, with an average range of 7.7%. In addition, the prevalence is reported to be 7% among women within 30 years of age, which is poised to increase to 22%, thereby making it suitable for the market to gain increased exposure globally.

Product Segment Analysis

Based on the product, the consumables and accessories segment in the faecal extraction system market is expected to account for the third-largest share by the end of the projected period. The segment’s development is highly driven by its supremacy, which is readily anchored in the crucial razor-and-blade business model. Besides, while evacuation pumps are considered a one-time purchase, every device requires a high-volume and continuous sterile supply, along with single-use components, such as sealing systems, collection canisters, and rectal catheters. Therefore, this develops a recurring and predictable revenue stream, which is extremely resilient and suitable for the segment’s growth internationally.

Our in-depth analysis of the market includes the following segments:

Segment

Subsegments

Technology

  • Automated/Suction-Based Systems
  • Manual Systems

Indication

  • Chronic Fecal Incontinence
    • Neurological Disorders
    • Age-Related
  • Acute Care
    • Post-operative Care
    • Critical Care

Product

  • Consumables & Accessories
    • Rectal Catheters
    • Collection Canisters
    • Seals
  • Evacuation Pumps & Kits

End user

  • Hospitals
    • Consumables & Accessories
    • Evacuation Pumps & Kits
  • Ambulatory Surgical Centers
  • Long-Term Care Centers

Patient Care Setting

  • Long-Term Care Facilities & Nursing Homes
  • Hospitals
    • Intensive Care Units
    • Surgical Wards
  • Home Care Settings

Capacity

  • 1000 to 2000 gallon
    • 1000 to 1500 gallon
    • 1500 to 2000 gallon
  • Greater than 2000 gallon
  • Less than 2000 gallon

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of the faecal extraction system market was over USD 2 billion.

The market size for the faecal extraction system market is projected to reach USD 1.9 billion in 2025 and is projected to reach USD 3.2 billion by the end of 2035, rising at a CAGR of 6.3% during the forecast period, i.e., 2026-2035.

The major players in the market are Thermo Fisher Scientific, QIAGEN N.V., Promega Corporation, Roche Diagnostics, Abbott Laboratories, Danaher (Cepheid), bioMérieux SA, BÜHLMANN Laboratories AG, ALPCO, Arbor Assays, DRG Instruments, Svar Life Science / Calpro AS, Bioserv Diagnostics, Epitope Diagnostics, Meridian Bioscience, and others.

In terms of type, automated/suction-based systems segment in the faecal extraction system market is anticipated to account for the largest share of 83.5% by the end of 2035

The North America market is projected to garner 48.2% market share by 2035, driven by government screening expansion and robust payer support.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos